HEAL — Restart Life Sciences Share News
0.000.00%
Last trade - 00:00- CA$4.68m
- CA$4.26m
Brief: Nova Mentis Files Genetic Neuroinflammatory Disease Patent
Brief: U.S. FDA Approves Nova Mentis Orphan Drug Application
Brief: Nova Mentis Launches Autism Clinical Study
Brief: Nova Mentis Life Science Says Co Approved For Trading On OTCQB Venture Market Effective Mar. 10
Brief: Nova Mentis Life Science Corp Says Added Two Additional Psychedelic Compounds To Its Drug Portfolio
Brief: Liberty Leaf Says Subsidiary Just Kush Has Initiated Its First Crop Of Plants
Brief: Liberty Leaf Holdings Says Unit Has Been Issued Standard Cultivation, Standard Processing & Sale For Medical Purposes Licences From Health Canada